BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/23/2024 9:20:02 AM | Browse: 22 | Download: 0
Publication Name World Journal of Clinical Cases
Manuscript ID 93435
Country China
Category Agriculture, Dairy & Animal Science
Manuscript Type Clinical and Translational Research
Article Title Unraveling the mechanism of malancao in treating ulcerative colitis: A multi-omics approach
Manuscript Source Unsolicited Manuscript
All Author List Xing-Long Huang, Lu-Na Wu, Qin Huang, Yue Zhou, Lei Qing, Feng Xiong, Hui-Ping Dong, Tai-Min Zhou, Kai-Li Wang and Jue Liu
Funding Agency and Grant Number
Funding Agency Grant Number
The Chongqing Science and Health Joint Chinese Medicine Technology Innovation and Application Development Project No. 2022MSXM209
Corresponding Author Jue Liu, PhD, Lecturer, ., Hospital of Traditional Chinese Medicine in Qijiang District, No. 69 Huideng Road, Tonghui Street, Qijiang District, Chongqing 401420, China. 30112067@qq.com
Key Words Malancao; Ulcerative colitis; Mass spectrum; Network pharmacology; Molecular docking
Core Tip Eleven primary active constituents (nicotinic acid, luteolin, kaempferol, genkwanin, bessisterol, aloe emodin, wogonin, stigmasterol, rhein, quercetin, oroxylin A) and five key genes (AKT1, JUN, HSP90AA1, CASP3, IL6) were identified in malancao (MLC). Furthermore, three principal signaling pathways were determined through enrichment analysis from the Kyoto Encyclopedia of Genes and Genomes, suggesting that MLC exhibits a multi-component, multi-target, and multi-pathway approach in the treatment of ulcerative colitis.
Citation Huang XL, Wu LN, Huang Q, Zhou Y, Qing L, Xiong F, Dong HP, Zhou TM, Wang KL, Liu J. Unraveling the mechanism of malancao in treating ulcerative colitis: A multi-omics approach. World J Clin Cases 2024; In press
Received
2024-02-27 10:00
Peer-Review Started
2024-02-27 10:00
To Make the First Decision
Return for Revision
2024-04-04 03:39
Revised
2024-04-11 12:25
Second Decision
2024-04-23 02:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-04-23 09:20
Articles in Press
2024-04-23 09:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com